Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Final results of a randomized...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Export Ready —
Final results of a randomized trial comparing autotransplant versus wait and watch in 222 patients with CLL in 1(st) or 2(nd) remission (EBMT CLL auto trial / GCLLSG CLL3R trial)
Bibliographic Details
Main Authors:
McClanahan, F
,
Michallet, M
,
Milligan, D
,
Sutton, L
,
Brand, R
,
Richards, S
,
Van Biezen, A
,
Sobh, M
,
Gratwohl, A
,
Herr, W
,
Dearden, C
,
Hallek, M
,
Stilgenbauer, S
,
De Witte, T
,
Niederwieser, D
,
Leporrier, M
,
Dreger, P
Format:
Journal article
Published:
2010
Holdings
Description
Similar Items
Staff View
Similar Items
Autologous haematopoietic stem cell transplantation in CLL: first results of an EBMT randomized trial comparing autotransplant versus wait and watch
by: Michallet, M, et al.
Published: (2010)
Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch
by: Michallet, M, et al.
Published: (2009)
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN CLL: FIRST RESULTS OF AN EBMT RANDOMIZED TRIAL COMPARING AUTOTRANSPLANT VERSUS WAIT AND WATCH
by: Michallet, M, et al.
Published: (2010)
The role of trephine bone marrow biopsies in the era of measurable residual disease—Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
by: Nadine Kutsch, et al.
Published: (2024-07-01)
P641: RETREATMENT WITH VENETOCLAX AFTER VENETOCLAX, OBINUTUZUMAB +/- IBRUTINIB: POOLED ANALYSIS OF 13 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN GCLLSG TRIALS
by: P. Cramer, et al.
Published: (2022-06-01)